Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Torti

Showing results (71-80 of 263) with videos related to

Pageof 27
Sort By:
BMC Infectious Diseases|July 20, 2014
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in ItalyMarco Franzetti, Michela Violin, Andrea Antinori, et al.
Le Infezioni in Medicina|June 1, 2021
Outcome of HBV screening and vaccination in a migrant population in southern ItalyMaria Mazzitelli, Giuseppe Greco, Francesca Serapide, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut MicrobiotaAlessandro Russo, Francesca Serapide, Angela Quirino, et al.
Clinical Case Reports|June 4, 2021
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a "spontaneous" complication?Anna Cancelliere, Giada Procopio, Maria Mazzitelli, et al.
Drug Safety|November 27, 2007
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patientsCarlo Torti, Silvia Costarelli, Annalisa De Silvestri, et al.
Plos Pathogens|May 30, 2009
Increasing clinical virulence in two decades of the Italian HIV epidemicViktor Müller, Franco Maggiolo, Fredy Suter, et al.
Epidemiologia E Prevenzione|July 16, 2013
[A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009]Alessandra Calabresi, Alice Ferraresi, Rosa Maria Limina, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2003
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based settingCarlo Torti, Salvatore Casari, Loredana Palvarini, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2011
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapyJuliette Pavie, Raphael Porcher, Carlo Torti, et al.
Journal of Medical Virology|March 25, 2008
Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: a single center analysisGiuseppe Lapadula, Ilaria Izzo, Franco Gargiulo, et al.
Pageof 27

Showing results (71-80 of 263) with videos related to

Sort By:
Pageof 27
BMC Infectious Diseases|July 20, 2014
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in ItalyMarco Franzetti, Michela Violin, Andrea Antinori, et al.
Le Infezioni in Medicina|June 1, 2021
Outcome of HBV screening and vaccination in a migrant population in southern ItalyMaria Mazzitelli, Giuseppe Greco, Francesca Serapide, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut MicrobiotaAlessandro Russo, Francesca Serapide, Angela Quirino, et al.
Clinical Case Reports|June 4, 2021
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a "spontaneous" complication?Anna Cancelliere, Giada Procopio, Maria Mazzitelli, et al.
Drug Safety|November 27, 2007
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patientsCarlo Torti, Silvia Costarelli, Annalisa De Silvestri, et al.
Plos Pathogens|May 30, 2009
Increasing clinical virulence in two decades of the Italian HIV epidemicViktor Müller, Franco Maggiolo, Fredy Suter, et al.
Epidemiologia E Prevenzione|July 16, 2013
[A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009]Alessandra Calabresi, Alice Ferraresi, Rosa Maria Limina, et al.
Health Policy (Amsterdam, Netherlands)|August 28, 2003
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based settingCarlo Torti, Salvatore Casari, Loredana Palvarini, et al.
The Journal of Antimicrobial Chemotherapy|August 9, 2011
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapyJuliette Pavie, Raphael Porcher, Carlo Torti, et al.
Journal of Medical Virology|March 25, 2008
Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: a single center analysisGiuseppe Lapadula, Ilaria Izzo, Franco Gargiulo, et al.
Pageof 27